Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Change in Accured Expenses (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Change in Accured Expenses for 17 consecutive years, with $43.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 807.06% year-over-year to $43.6 million, compared with a TTM value of $61.6 million through Dec 2025, up 2647.3%, and an annual FY2025 reading of $22.9 million, up 166.13% over the prior year.
  • Change in Accured Expenses was $43.6 million for Q4 2025 at Dolby Laboratories, down from $71.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $71.8 million in Q3 2025 and bottomed at -$105.3 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is -$2.0 million, with a median of $5.3 million recorded in 2021.
  • Peak annual rise in Change in Accured Expenses hit 935.69% in 2023, while the deepest fall reached 1469.91% in 2023.
  • Year by year, Change in Accured Expenses stood at -$34.0 million in 2021, then soared by 116.94% to $5.8 million in 2022, then crashed by 654.95% to -$32.0 million in 2023, then skyrocketed by 115.02% to $4.8 million in 2024, then surged by 807.06% to $43.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for DLB at $43.6 million in Q4 2025, $71.8 million in Q3 2025, and -$76.2 million in Q2 2025.